Jasper Therapeutics Completes The Acquisition Of Kira Pharmaceuticals; Announces $132M Private Placement Of Convertible Preferred Stock; Combined Company Operations Expected To Be Funded Through Second Half Of 2028

Loading news article.

Jasper Therapeutics Completes The Acquisition Of Kira Pharmaceuticals; Announces $132M Private Placement Of Convertible Preferred Stock; Combined Company Operations Expected To Be Funded Through Second Half Of 2028 | WAPE

Jasper Therapeutics Completes The Acquisition Of Kira Pharmaceuticals; Announces $132M Private Placement Of Convertible Preferred Stock; Combined Company Operations Expected To Be Funded Through Second Half Of 2028

Article summary

Related companies

Comments —